About a-team Marketing Services
The knowledge platform for the financial technology industry

A-Team Insight Briefs

Bloomberg Launches New SFDR Tool for Asset Managers

Subscribe to our newsletter

Bloomberg’s fund manager clients can access a new tool enabling them to identify assets aligned with the European Union’s Sustainable Finance Disclosure Regulation (SFDR). The dashboard-based offering is available through Bloomberg’s Terminal.

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: Managing data for the Fundamental Review of the Trading Book (FRTB)

The January 1, 2022 compliance deadline for Fundamental Review of the Trading Book (FRTB) regulation may be three years out, but if your organisation is within scope of the rules, the time to address their data management challenges is now. Will your organisation be able to source the necessary data for non-modellable risk factors (NMRFs)...

BLOG

A-Team Group Announces Winners of RegTech Insight Awards Europe 2026

A-Team Group has announced the winners of its RegTech Insight Awards Europe 2026. The awards recognise both established providers and innovative newcomers providing RegTech solutions to capital market participants that significantly improve their ability to respond effectively to evolving and increasingly complex regulatory requirements. This year’s RegTech Insight Awards Europe included categories spanning the regulatory...

EVENT

Eagle Alpha Alternative Data Conference, London, hosted by A-Team Group

Now in its 8th year, the Eagle Alpha Alternative Data Conference managed by A-Team Group, is the premier content forum and networking event for investment firms and hedge funds.

GUIDE

Alternative Trading Systems Directory 2010

The year since we launched our first edition of the A-Team Alternative Trading Directory has passed by in a flash (no pun intended). And while the rate of expansion of the alternative trading system sector may have slowed – even consolidated somewhat – in the more established centres, their onward march continues both in terms of credibility, and of uptake...